A PHASE-II STUDY OF DUP-937 (TELOXANTRONE) IN METASTATIC MALIGNANT-MELANOMA - A STUDY OF THE NATIONAL-CANCER-INSTITUTE-OF-CANADA CLINICAL-TRIALS GROUP (NCICCTG)
T. Shore et al., A PHASE-II STUDY OF DUP-937 (TELOXANTRONE) IN METASTATIC MALIGNANT-MELANOMA - A STUDY OF THE NATIONAL-CANCER-INSTITUTE-OF-CANADA CLINICAL-TRIALS GROUP (NCICCTG), Annals of oncology, 4(8), 1993, pp. 695-696